Text Size

Glaucoma Research Foundation Gala Honors San Francisco Philanthropists Frank Stein and Paul S. May

San Francisco, January 10, 2013 — Glaucoma Research Foundation President and CEO, Thomas M. Brunner announced today that San Francisco philanthropists Frank Stein and Paul S. May will receive The Catalyst Award at the organization’s annual Catalyst For A Cure benefit gala at the historic Palace Hotel on Thursday, January 31.


The Catalyst Award, Glaucoma Research Foundation’s highest honor, recognizes exemplary leadership in sustaining innovative glaucoma research and education. “Frank and Paul’s support is most heartfelt and demonstrates their extraordinary commitment to finding a cure for glaucoma,” Mr. Brunner said.

Stein and May are dedicated to advancing glaucoma research and making low vision services available to the San Francisco community. In 2008, they established The Frank Stein and Paul S. May Grants for Innovative Glaucoma Research, providing generous support to underwrite promising individual investigator grants. Their commitment fosters the entrepreneurial spirit of scientific discovery. They join an illustrious group of prior recipients that include Richard L. Lindstrom, MD, June Behrendt, Jeffrey B. Kindler, H. Dunbar Hoskins, Jr., MD, Cary Rayment, F. T. Barr, David E. I. Pyott, and Steven and Michele Kirsch.

Co-chaired by Nobuko Saito Cleary and Gary Cleary, PharmD, PhD, the Catalyst For A Cure gala includes a reception and silent auction in the Garden Court and dinner in the Gold Ballroom as guests celebrate the scientists who have done so much to help in the fight against glaucoma. Highlights of the Benefit program include presentation of Glaucoma Research Foundation’s most prestigious Catalyst Award and a live auction to raise funds in support of glaucoma research.


This year, Glaucoma Research Foundation celebrates 35 years of success and accomplishment that have made the organization one of the nation’s driving forces in elevating glaucoma as a national health priority. Founded in San Francisco in 1978, GRF is America’s oldest and most experienced institution dedicated solely to its mission: Preventing vision loss from glaucoma by investing in innovative research, education and support with the ultimate goal of finding a cure. GRF has a proven track record of results-oriented and innovative research, and produces definitive educational materials used by eye care professionals across the country. The Glaucoma Research Foundation website, www.glaucoma.org, provides valuable information about glaucoma to one million visitors annually.

Glaucoma is a leading cause of blindness in the world affecting more than 60 million people. African Americans, Asians and Hispanics have a greater prevalence of glaucoma, a disease known as “the silent thief of sight” because there are no symptoms. Early diagnosis and treatment can prevent vision loss so it is important that everyone receive complete eye examinations for glaucoma. People over age 60 are at higher risk as are those whose family members have glaucoma.

Last reviewed on October 29, 2017

Was this helpful? Yes No